Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: Airfinity; Chart: Andrew Witherspoon/Axios

The Biden administration took its biggest step yet toward becoming a global supplier of coronavirus vaccines, announcing that it would export 60 million AstraZeneca doses over the next several weeks.

Why it matters: President Biden has been under intense global scrutiny for his "Americans first" approach. Alone among the four major producers, the U.S. has kept nearly its entire supply up to now.

  • The biggest symbol of Washington's "vaccine nationalism" had been the stockpiling of the AstraZeneca vaccine — not approved and not needed in the U.S., but crucial to many countries' rollouts.
  • A senior administration official told reporters tonight that just 10 million doses were waiting to be distributed (much lower than had been reported), while another 50 million doses would be ready by June.

Those doses will be exported around the world, pending an FDA safety review, but the White House says no decisions have been made as to which countries will receive them.

  • India could be near the top of the list given the terrifying outbreak there, though the White House says Prime Minister Narendra Modi did not request doses in a call with Biden today.
  • So too could Mexico, which has turned to Russia and China in search of vaccines despite bordering one of the world's largest producers.
Expand chart
Note: This map represents the total number of vaccines administered, not people vaccinated; Data: Our World in Data; Map: Danielle Alberti/Axios

Breaking it down: While relatively small compared to the 231 million doses the U.S. has already administered, 60 million doses would be a major boost to the severely strained global supply.

  • The COVAX initiative, the primary source of vaccines for dozens of lower-income countries, has thus far only distributed 45 million doses globally.
  • Still, now that Biden has shown he's willing to export the vaccine the U.S. isn't using, the obvious next question is when he'll allow exports of the ones it is: Pfizer, Moderna and Johnson & Johnson.

What to watch: Nearly every U.S. adult who wants a vaccine will likely have had one within the next two to three weeks, Axios' Caitlin Owens reports.

  • And as demand begins to wane, supply should continue to ramp up. Pfizer, Moderna, J&J and AstraZeneca still owe the U.S. hundreds of millions of doses (more still if Biden exercises additional purchase options).
  • Biden will face international pressure and public health imperatives to share those doses with the world. He has said that he hopes to do so once the U.S. has a "surplus" but offered no clarity as to what qualifies as a surplus or where the doses will go.
  • On the one hand: The Biden administration has emphasized the need for caution and flexibility at home, citing possible production disruptions, the likely need for booster shots and the possibility of vaccinating children.
  • On the other: Secretary of State Tony Blinken has said the U.S. will become "the world leader in helping to make sure that the entire world gets vaccinated."

The bottom line: Even as the U.S. puts billions of dollars toward that goal, it has been unwilling to tap the biggest asset at Biden's disposal: the doses streaming out of U.S. factories each week.

Go deeper

Aug 4, 2021 - Health

New York City revives vaccine passports

Illustration: Aïda Amer/Axios

New York City yesterday became the first city in the U.S. to require proof of coronavirus vaccination for indoor dining and other leisure activities, a measure popular among public health experts but previously squashed by political backlash to "vaccine passports."

Why it matters: Employers and now local governments are starting to ensure that remaining unvaccinated will have consequences for everyday life, testing the resolve of those who say nothing could persuade them to get a shot.

Aug 3, 2021 - Health

Israel reinstates COVID-19 restrictions as cases surge

Elderly residents wait to receive their third dose of the Pfizer-BioNTech Covid-19 vaccine at a medical center in Tel Aviv on Aug. 2. Photo: Kobi Wolf/Bloomberg via Getty Images

Israel announced Tuesday it will tighten public health measures due to surging in COVID-19 case numbers.

Driving the news: The latest restrictions come as Israel saw nearly 4,000 new daily cases reported on Tuesday, the highest count so far since the country began experiencing an uptick last month, the AP reports.

Aug 4, 2021 - Health

America's pandemic pessimism returns

Data: Harris Poll; Chart: Axios Visuals

A majority of Americans now, once again, say the worst of the pandemic is yet to come, per new Harris polling provided exclusively to Axios.

Why it matters: We took a brief hiatus from worrying about the pandemic, but the Delta variant and the response to it appear to have sent us back to a dark place.